Bio99(@BIO99_BIO99) 's Twitter Profile Photo

My comments on the stunning preprint submission to Nature about $NWBO DCVax-polyICLC are here. Hello Checkpoint Inhibitors! Hello $MRK $REGN $PFE $JNJ $BMY and a lot of others. reddit.com/r/NWBO/comment…

account_circle
Tommy Bax 🇬🇧 🇹🇼(@TommyBaxendale) 's Twitter Profile Photo

$NWBO Combination therapies for the never-seen-before win in cancer treatment! For example:
( ) + Immunostimulant (TLR-3 agonist) + Immune Response Modifier = 50% overall survival @ 100mths.
🧠💉🚀

$NWBO Combination therapies for the never-seen-before win in cancer treatment! For example:
#DCVax ( #murcidencel ) + Immunostimulant (TLR-3 agonist) #PolyICLC + Immune Response Modifier #Resiquimod = 50% overall survival @ 100mths. 
🧠💉🚀
#fuckcancer
account_circle
KModyMD(@kmody29) 's Twitter Profile Photo

Anti-NY ESO and Dendritic Cell agonist with polyICLC significantly increase dendritic cells to tumors and all patients responded!

Anti-NY ESO and Dendritic Cell agonist with polyICLC significantly increase dendritic cells to tumors and all patients responded! #SITC2016
account_circle
Jake Davis(@WewokaChronicle) 's Twitter Profile Photo

New cancer clinical trial: Neoadjuvant Hiltonol® (PolyICLC) for Prostate Cancer bit.ly/2vvFtqN Condition:   Prostate CancerInterv…

New cancer clinical trial: Neoadjuvant Hiltonol® (PolyICLC) for Prostate Cancer bit.ly/2vvFtqN Condition:   Prostate CancerInterv…
account_circle
🇺🇸🤝🇺🇦eastvillagetwt(@eastvillagetwt) 's Twitter Profile Photo

The White House War On Glioblastoma

An answer is coming and it is going to do immense work with other drugs to strike a blow against .

$NWBO forbes.com/sites/forbeseq…

account_circle
GoodguyGoneBad(@GoneGoodguy) 's Twitter Profile Photo

This and the DCVAX + PDL-1 + PolyICLC moving from p1 to p2 could explain why NWBO is taking so long to apply for approval.

account_circle
autologous assassin 🇺🇸 🇺🇦 🇮🇱(@flaskworks) 's Twitter Profile Photo

Over the next few months $NWBO shareholders should receive MHRA approval for DCVax on newly diagnosed and recurrent Glioblastoma, updates on the Flaskworks manufacturing process, publication of Landmark PII DCVax PolyICLC trial in Nature, as well as partnership announcements.

Over the next few months $NWBO shareholders should receive MHRA approval for DCVax on newly diagnosed and recurrent Glioblastoma, updates on the Flaskworks manufacturing process, publication of Landmark PII DCVax PolyICLC trial in Nature, as well as partnership announcements.
account_circle
🇺🇸🤝🇺🇦eastvillagetwt(@eastvillagetwt) 's Twitter Profile Photo

Expanding number of patients who get significant increases in Survival (OS) w/out Progression for Glioblastoma & Brain Tumors w/ may come w/ as Adjuvant & Combination Therapies. $NWBO

Could it be as high as 50% to 100 months & more?

account_circle
Oncovir, Inc.(@oncovir) 's Twitter Profile Photo

We have begun a Phase I study for COVID-19! The trial is being conducted at the University of Calgary and is funded via a contribution agreement from the Government of Canada under the DND IDEaS program and DRDC!
ucalgary.ca/research/parti…

account_circle